Clinical Trial Update: Valnoctamide in Mania [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of valnoctamide for mania has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mania
• Schizoaffective Disorder Manic Type

Drugs mentioned

• Valnoctamide (valnoctamide)

Snippet

Sponsor: Beersheva Mental Health Center | Conditions: Mania, Schizoaffective Disorder, Manic Type | Phase 3 | Status: COMPLETED